CRBU Dividend: Caribou Biosciences Inc Yield Insights

Income

Balance sheet

Cash flow

Annual

Quarterly

CRBU Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	9	9	34	13	9	12
Revenue Growth (YoY)	-18%	-74%	162%	44%	-25%	140%
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	39	46	38	38	24	14
Research & Development	116	130	112	82	52	34
Operating Expenses	155	176	150	120	76	48
Other Non Operating Income (Expenses)	10	17	14	7	-1	0
Pretax Income	-157	-149	-101	-99	-66	-36
Income Tax Expense	--	0	0	0	0	-1
Net Income	-157	-149	-102	-99	-66	-34
Net Income Growth	6%	46%	3%	50%	94%	48%
Shares Outstanding (Diluted)	93.29	90.31	73.8	60.8	60.26	56.71
Shares Change (YoY)	3%	22%	21%	1%	6%	0%
EPS (Diluted)	-1.69	-1.65	-1.38	-1.64	-1.11	-0.6
EPS Growth	3%	19%	-16%	48%	85%	46%
Free Cash Flow	-127	-143	-104	-97	-34	-33
Free Cash Flow Per Share	-1.36	-1.58	-1.4	-1.59	-0.56	-0.58
Gross Margin	--	--	--	--	--	--
Operating Margin	-1,622.22%	-1,844.44%	-341.17%	-815.38%	-733.33%	-300%
Profit Margin	-1,744.44%	-1,655.55%	-300%	-761.53%	-733.33%	-283.33%
Free Cash Flow Margin	-1,411.11%	-1,588.88%	-305.88%	-746.15%	-377.77%	-275%
EBITDA	-142	-163	-113	-105	-66	-36
EBITDA Margin	-1,577.77%	-1,811.11%	-332.35%	-807.69%	-733.33%	-300%
D&A For EBITDA	4	3	3	1	0	0
EBIT	-146	-166	-116	-106	-66	-36
EBIT Margin	-1,622.22%	-1,844.44%	-341.17%	-815.38%	-733.33%	-300%
Effective Tax Rate	--	0%	0%	0%	0%	2.77%